| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,950 | $30 | $134.3K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 10,350 | $10 | $103.5K |
| J3262 | Injection, tocilizumab, 1 mg | 12,720 | $10 | $63.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 990 | $30 | $25.7K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 910 | $30 | $23.7K |
| J0897 | Injection, denosumab, 1 mg | 720 | $20 | $13.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 100 | $90 | $9.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 60 | $100 | $5.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 40 | $120 | $4.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 90 | $50 | $4.3K |